Synchronised ECG and PPG Data Collection for AI-based QT/QTc Reconstruction (ILECS-ECGPPG)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCorsano Health B.V.
About this trial
This observational study will collect synchronized photoplethysmography (PPG) and electrocardiogram (ECG) recordings from approximately 50 healthy adult volunteers. Participants will wear the Corsano CardioWatch 297-2 and a reference ECG device simultaneously for approximately 24 hours, including standardized activities and free-lining conditions. The objective is to generate a high-quality paired ECG-PPG dataset to support the development and evaluation of artificial intelligence methods fro reconstructing ECG parameters, with a particular focus on QT/QTc, from PPG signals. The study will also evaluate the feasibility and usability of the wearable monitoring system.
Eligibility criteria
Qualifiers
Able to provide written informed consent.
Willing and able to comply with all study procedures and attend the required study visits.
Age ≥18 years.
Able to read or understand Dutch or English.
Disqualifiers
Children/minors or vulnerable individuals.
Skin conditions or allergies preventing safe wear of the CardioWatch or ECG electrodes.
Any condition that, in the investigator's opinion, may interfere with study completion or data quality.
Compromised circulation, injury, or physical malformation at sensor sites.
Trial design
Treatments tested in this trial
- Corsano CardioWatch 287-2
- VivaLNK wearable ECG patch
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov